Poniard plunges on failure of picoplatin study Poniard plunges on failure of picoplatin study - WCAX.COM Local Vermont News, Weather and Sports-

WCAX.COM Local Vermont News, Weather and Sports-Poniard plunges on failure of picoplatin study

* Log In

* Log Out

* In The Garden

* Changing Seasons

* School Closings

* * Windsor, Springfield Set for Title Game Re-match

* Champions Crowned in High School Soccer

* Top 3 on 3

* Milo, Spillane Lead IceCats to Win over Providence

* Panther Field Hockey Headed to NCAA Tournament Regional

* Essex Claims Division One Football Championship

* Colchester, Windsor Celebrate State Titles

* WCAX Sports Team

* National Sports

* Email

* Print

Poniard plunges on failure of picoplatin studyPosted: Monday, November 16, 2009 12:52 PM ESTUpdated: Monday, November 16, 2009 12:52 PM EST

Local News More}}

Shumlin Running for Governor

Police Officer's Animal Cruelty Trial Begins

Sheffield Man Killed in Hang-Gliding Accident

* Sell your home

* Search homes for sale

* Get new home listings alerts More}}

NEW YORK (AP) - Shares of Poniard Pharmaceuticals Inc. crashed Monday after the company said its cancer drug picoplatin missed its goal in a clinical trial.

The company said patients who took picoplatin as a treatment for relapsed lung cancer did not survive significantly longer than those who received only the best available care. In afternoon trading, Poniard shares dropped $5.92, or 78.1 percent, to $1.66, their lowest price since March.

"This is clearly a disappointing and surprising outcome," said BMO Capital Markets analyst Jason Zhang. He said picoplatin appeared to work as well as it had in earlier studies, but other treatments worked better than expected. Zhang previously thought picoplatin had a "reasonably good chance" of succeeding, and expected patients on the drug would live 35 to 40 percent longer.

Zhang thinks the Food and Drug Administration probably won't approve picoplatin based on results from the late stage trial, and noted the South San Francisco company is running low on cash. He downgraded Poniard shares to "Market Perform" from "Outperform."

About 26 million Poniard shares changed hands by early afternoon. In a typical full day, about 708,000 shares are traded.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

All content (c) Copyright 2001 - 2009 WorldNow and WCAX. All Rights Reserved.

For more information on this site, please read our Privacy Policy and Terms of Service.

concept		evidence	hits	links
	$drugwar_propaganda 70% [news] [concept]	$propaganda_theme2		Classic Modern Drug Propaganda Themes in Chemical Prohibition Drug War Propaganda (book)
	$propaganda_theme2 70% [news] [concept]	"cancer" "Accident"	3	Madness,Crime,Violence,Illness (propaganda theme 2) http://www.drugwarfacts.org/crime.htm http://www.drugwarfacts.org/causes.htm Distortion 18: Cannabis and Mental Illness
	$drugs [news] [concept]	$various_drugs
	$various_drugs [news] [concept]	"Pharmaceuticals" "drug"	4
	$school [news] [concept]	"School"	2	http://www.ssdp.org/

observer's propaganda picks

See drug-warrior propaganda somewhere?
Submit text or a url, and bot will analyze prohibition propaganda for you!

Prohibition-era cartoons
Anti-prohibition political cartoons from Prohibition I.

Donate to drugsense please give generously!